Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Filings indexed 1,245 across all filing types
Latest filing 2021-08-30 Regulatory Filings
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Record Date
Regulatory Filings Classification · 90% confidence The document is extremely short (411 characters) and consists mainly of addresses and stock exchange listing department references. There is no substantive financial data, report content, or detailed information. It appears to be a brief communication or notice related to stock exchange listing, without any report or announcement content. Given the lack of detailed content and the nature of the text, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2021-08-30 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document contains multiple references to notices and advertisements related to Annual General Meetings (AGMs), including details about e-voting, book closure, and meeting dates. It specifically mentions the "Notice of 36th Annual General Meeting" and the "Notice of the 48th Annual General Meeting" for different companies. The content is primarily about the announcement and procedural information for AGMs rather than the full AGM materials or presentations. The document is about the publication of these notices in newspapers and dissemination to shareholders, which aligns with announcements related to AGM information rather than the AGM report or presentation itself. Therefore, the document fits best under the category of AGM Information (AGM-R). The document length is substantial but the content is focused on the notice and related procedural information, not the full annual report or financial statements.
2021-08-30 English
Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of newspaper advertisements pertaining to Notice ....
AGM Information Classification · 95% confidence The document contains multiple references to notices and advertisements related to Annual General Meetings (AGMs), including details about the 36th and 48th AGMs of different companies. It mentions e-voting procedures, book closure information, and the scheduling of the AGMs to be held via video conferencing. The document includes newspaper advertisements and official notices sent to stock exchanges, which are typical for announcements related to AGMs. There is no detailed financial data, management discussion, or audit information present. The document is primarily an announcement of the AGM notice and related procedural information, not the AGM materials or reports themselves. Therefore, the document fits the category of AGM Information (AGM-R).
2021-08-30 English
Pursuant to Regulation 34(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed ....
Annual Report Classification · 100% confidence The document is a detailed communication addressed to stock exchanges (NSE and BSE) regarding the Annual Report for the financial year 2020-21 and the Notice convening the 36th Annual General Meeting (AGM) of Bliss GVS Pharma Limited. It references Regulation 34(1) of SEBI Listing Regulations, which mandates the submission of annual reports. The text includes a comprehensive table of contents typical of an annual report, including sections such as Board of Directors, Management Discussion and Analysis, Corporate Governance Report, Auditor's Report, and Financial Statements. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of detailed corporate information, financial highlights, and statutory sections confirms this is the full Annual Report. Therefore, the correct classification is Annual Report (10-K).
2021-08-28 English
Copy of Newspaper Publication
AGM Information Classification · 90% confidence The document is a letter addressed to stock exchanges regarding a newspaper advertisement about the 36th Annual General Meeting (AGM) of Bliss GVS Pharma Ltd. It references the scheduling of the AGM and compliance with regulatory circulars. The content is primarily an announcement of the AGM notice publication rather than the AGM materials themselves. The document length is about 15,000 characters, but the content is focused on informing the exchanges about the advertisement of the AGM notice, not the AGM presentation or minutes. Therefore, it is best classified as AGM Information (AGM-R) since it relates to the AGM notice and related information.
2021-08-23 English
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of advertisement of public ....
AGM Information Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a newspaper advertisement about the 36th Annual General Meeting (AGM) of Bliss GVS Pharma Ltd. It references compliance with SEBI and MCA circulars related to the AGM and includes a public notice advertisement for the AGM. The content is primarily an announcement of the AGM and the publication of the advertisement, not the AGM materials themselves. The document length is about 15,000 characters, but the content is focused on the announcement of the AGM advertisement, not the AGM presentation or materials. Therefore, this fits best under AGM Information (AGM-R) as it relates to AGM-related communication, specifically the advertisement notice for the AGM. The document is not a full annual report, earnings release, or other financial report, nor is it a voting result or proxy solicitation. Hence, the classification is AGM-R with high confidence.
2021-08-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.